Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: RRM2 and CDC6 are novel effectors of XBP1-mediated endocrine resistance and predictive markers of tamoxifen sensitivity

Fig. 5

Ligand independent induction of RRM2, CDC6 and TOP2A in ESR1 mutant MCF7 cells. MCF7 WT, MCF7 Y537S, MCF7 D538G cells were synchronized for 3 days in phenol red free DMEM containing 5% CSS. MCF7 WT cells were either treated with (Veh) or estrogen (E2) for 24 h. Expression level of RRM2, CDC6, and TOP2A was evaluated by qRT-PCR and normalised against RPLP0. Data presented as mean ± S.D of three independent experiments. *p < 0.05, two-tailed unpaired t-test compared with vehicle treated MCF7 WT cells

Back to article page